Study of Heparin in Intestinal Ischemia and Reperfusion in Rats: Morphologic and Functional Evaluation

Transplantation Proceedings

Volumn 44, Issue 8, 2012, Pages 2300-2303

  Ghadie, M M ^a   Miranda Ferreira, R ^a   Taha, N S A ^a   Maroso, A S ^b   Moreti, R J Z ^b   Andraus, M P ^b   Zempulski, P ^b   Monteiro, H P ^a   Simoes M J ^a   Montero, E F S ^a   Fagundes, D J ^a   Caricati Neto, A ^a   Taha, M O ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Dourados Area Federal University (UFGD)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; HEPARIN; GASTROINTESTINAL AGENT; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FUNCTIONAL ANATOMY; INTESTINE CONTRACTION; INTESTINE FUNCTION DISORDER; INTESTINE INNERVATION; INTESTINE ISCHEMIA; INTESTINE MOTILITY; JEJUNUM; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; ANIMAL; CELL PROTECTION; DISEASE MODEL; DRUG EFFECT; ELECTROSTIMULATION; GASTROINTESTINAL MOTILITY; INNERVATION; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION; WISTAR RAT;

ANIMALS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HEPARIN; JEJUNUM; MALE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 84874801756     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.055     Document Type: Article

References (31)

1. Barie, P.S., Schemes against ischemia; solutions for reperfusion injury?. Crit Care Med, 27, 1999, 684.
2. Horton, J.W., Walker, P.B., Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J Appl Physiol, 74, 1993, 1515.
3. Schoenberg, M.H., Beger, H.G., Reperfusion injury after intestinal ischemia. Crit Care Med, 21, 1993, 1376.
4. Furness, J.B., Types of neurons in the enteric nervous system. J Auton Nerv Syst, 81, 2000, 87.
5. Bauer, A.J., Transplantation-induced injuries of the intestinal muscularis and its innervations from preservation to chronic rejection. Transplant Proc, 28, 1996, 2539.
6. Taha, M.O., Fraga, M.M., Bandeira, C.F., et al. Effect of preservation conditions on autonomic transmission in rat small bowel. Transplant Proc, 34, 2002, 102.
7. Taha, M.O., Fraga, M.M., Fagundes, D.J., et al. Effect of allopurinol on autonomic dysfunction in rat jejunal segments exposed to cold ischemic preservation for transplantation. Transplant Proc, 36, 2004, 293.
8. Taha, M.O., Fraga, M.M., Fagundes, D.J., et al. Ascorbic acid prevents autonomic dysfunction in rat jejunal submitted to cold ischemic preservation for transplantation. Transplant Proc, 36, 2004, 289.
9. Ohlstein, E.H., Douglas, S.A., Sung, C.P., et al. Carvedilol, a cardiovascular drug, preventsvascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci U S A, 90, 1993, 6189.
10. Yue, T.L., Lysko, P.G., Barone, F.C., et al. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection. Ann N Y Acad Sci, 738, 1994, 230.
11. Feuerstein, G.Z., Ruffolo Jr, R.R., Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J, 16, 1995, 38.
12. Lopez, B.L., Christopher, T.A., Yue, T.L., et al. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical–induced endothelial dysfunction. Pharmacology, 51, 1995, 165.
13. Culmsee, C., Krieglstein, J., Emerging pharmacotherapeutic strategies for the treatment of ischemic stroke. Drug Discov Today Ther Strat, 3, 2006, 621.
14. Longa, E.Z., Weinstain, P.R., Carlson, S., et al. Reversible middle cerebral artery occlusion without cranioectomy in rats. Stroke, 20, 1989, 84.
15. Love, S., Oxidative stress in brain ischemia. Brain Pathol, 9, 1999, 119.
16. White, B.C., Sullivan, J.M., DeGracia, D.J., et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci, 179, 2000, 1.
17. Margaill, I., Plotkine, M., Lerouet, D., Antioxidant strategies in the treatment of stroke. Free Radic Biol Med, 39, 2005, 429.
18. Fuh, K.C., Meneshian, A., Patel, C.B., et al. Signal transduction by reactive oxygen species: alternative paradigms for signaling specificity. Surgery, 131, 2002, 601.
19. Durukan, A., Tatlisumak, T., Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav, 87, 2007, 179.
20. Samama, M.M., Desnoyers, P.C., Conard, J., et al. Acute ischemic stroke and heparin treatments. Thromb Haemost, 78, 1997, 173.
21. Kay, R., Wong, K.S., Yu, Y.L., et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med, 333, 1995, 1588.
22. FISS bis Investigators Group. Fraxiparine in Ischemic Stroke Study (FISS bis). Cerebrovasc Dis, 8(Suppl 4), 1998, 19.
23. He, S.Q., Zhang, Y.H., Venugopal, S.K., et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion induced liver injury in mice. Liver Transpl, 12, 2006, 1869.
24. Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA, 279, 1998, 1265.
25. Berge, E., Sandset, P.M., Heparin in Acute Embolic Stroke Trial (HAEST). Cerebrovasc Dis, S1, 1999, 127.
26. Diener, H.C., Ringelstein, E.B., von Kummer, R., Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Stroke, 32, 2001, 22.
27. Bath, P.M., Lindenstrom, E., Boysen, G., Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet, 358, 2001, 702.
28. Taha, M.O., Gonçalves, P.F.Z.R.A., Vidigal, R.O.G., et al. Protective effects of heparin on hepatic ischemia and reperfusion lesions in rabbits. Transplant Proc, 41, 2009, 812.
29. Kimura, C., Oike, M., Heparin sulfate proteoglycan is essential to thrombin-induced calcium transients and nitric oxide production in aortic endothelial cells. Thromb Haemost, 100, 2008, 438.
30. Celik, A., Ersoy, O.F., Ozkan, N., et al. Comparison of the effects of heparin on flap necrosis. J Plast Reconstr Aesthet Surg, 63, 2010, 875.
31. Medeiros, V.P., Paredes-Gamero, E.J., Monteiro, H.P., Rocha, H.A., Trindade, E.S., Nader, H.B., Heparin-integrin interaction in endothelial cells: downstream signaling and heparin sulfate expression. J Cell Physiol, 2011.